Oncogenic roles of CEACAM6 in pancreatic ductal adenocarcinoma.

被引：0
|
作者：
Mahadevan, Daruka
Pandey, Ritu
Chen, Yuliang
Essif, Jacob
Al-Khinji, Aisha
机构：
[1] Univ Texas Hlth San Antonio, San Antonio, TX USA
[2] Arizona Canc Ctr, Tucson, AZ USA
[3] Univ Arizona, Ctr Canc, Tucson, AZ USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16744
引用
收藏
页数：1
相关论文
共 50 条
  • [31] NAMPT expression in stage I/II pancreatic ductal adenocarcinoma.
    Davis, Katelynn
    Dunseth, Craig
    Mott, Sarah L.
    Bellizzi, Andrew
    Chan, Carlos Hou Fai
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [32] CEACAM7 an early detection biomarker for pancreatic ductal adenocarcinoma
    Dhasmana, Anupam
    Dhasmana, Swati
    Khan, Sheema
    Yallapu, Murali M.
    Jaggi, Meena
    Chauhan, Subhash C.
    CANCER RESEARCH, 2023, 83 (07)
  • [33] Significance of CEACAM6 Expression in Cholangiocarcinoma
    Rocha, F. G.
    Torres, J.
    Katabi, N.
    Gonen, M.
    DeMatteo, R. P.
    Fong, Y.
    D'Angelica, M. I.
    Allen, P. J.
    Klimstra, D. S.
    Jarnagin, W. R.
    ANNALS OF SURGICAL ONCOLOGY, 2012, 19 : S117 - S117
  • [34] RETRACTED ARTICLE: CEACAM6 gene silencing impairs anoikis resistance and in vivo metastatic ability of pancreatic adenocarcinoma cells
    Mark S Duxbury
    Hiromichi Ito
    Michael J Zinner
    Stanley W Ashley
    Edward E Whang
    Oncogene, 2004, 23 : 465 - 473
  • [35] The role of p53 in the development of pancreatic ductal adenocarcinoma.
    Hanson, Kathryn J.
    Flowers, Brittany M.
    Hughes, Nicholas
    Vogel, Hannes
    Cong, Le
    Attardi, Laura D.
    CANCER RESEARCH, 2021, 81 (22) : 58 - 58
  • [36] The role of whole genome duplication in progression of pancreatic ductal adenocarcinoma.
    Hummel, Lauren
    Xie, Irene
    Ng, Karen
    Zhang, Amy
    Ramotar, Stephanie
    Dodd, Anna
    O'Kane, Grainne
    Knox, Jennifer
    Wilson, Julie
    Gallinger, Steven
    Notta, Faiyaz
    CANCER RESEARCH, 2022, 82 (22) : 81 - 81
  • [37] Prognostic influence of waiting time in management of pancreatic ductal adenocarcinoma.
    Suzuki, Rei
    Takagi, Tadayuki
    Hikichi, Takuto
    Ohira, Hiromasa
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [38] Targeting importin-YAP axis in pancreatic ductal adenocarcinoma.
    Zeng, Renya
    Dong, Jixin
    CANCER RESEARCH, 2022, 82 (12)
  • [39] Efficacy and tolerability of tremelimumab in patients with metastatic pancreatic ductal adenocarcinoma.
    Sharma, Padmanee
    Dirix, Luc
    De Vos, Filip Yves Francine Leon
    Allison, James Patrick
    Decoster, Lore
    Zaucha, Renata
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [40] Cell-density dependent migration in pancreatic ductal adenocarcinoma.
    Karl, M.
    Jayatilaka, H.
    Wirtz, D.
    MOLECULAR BIOLOGY OF THE CELL, 2017, 28
12345